Butriptyline: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Short description|Overview of the antidepressant drug Butriptyline}} | |||
{{Drugbox | |||
| image = Butriptyline.svg | |||
| image_size = 200px | |||
| image_alt = Chemical structure of Butriptyline | |||
}} | |||
'''Butriptyline''', also known by its trade name '''Evadyne''', is a [[tricyclic antidepressant]] (TCA) that was developed in the 1960s. It is primarily used for the treatment of [[depression (mood)|depression]]. | |||
Butriptyline' | |||
== | ==Pharmacology== | ||
Butriptyline is | Butriptyline is a member of the [[tricyclic antidepressant]] class, which works by inhibiting the reuptake of [[neurotransmitter|neurotransmitters]] such as [[serotonin]] and [[norepinephrine]] in the brain. This action increases the levels of these neurotransmitters in the synaptic cleft, thereby enhancing mood and alleviating depressive symptoms. | ||
== | ===Mechanism of Action=== | ||
[[File:Butriptyline.svg|thumb|right|Chemical structure of Butriptyline]] | |||
Butriptyline acts primarily as a [[serotonin-norepinephrine reuptake inhibitor]] (SNRI). It also has affinity for various [[receptor (biochemistry)|receptors]], including [[histamine receptor|histamine]] and [[muscarinic acetylcholine receptor|muscarinic]] receptors, which contributes to its side effect profile. | |||
== | ==Clinical Use== | ||
Butriptyline is | Butriptyline is indicated for the treatment of major depressive disorder. It is less commonly used today due to the availability of newer antidepressants with more favorable side effect profiles. | ||
== | ===Side Effects=== | ||
Butriptyline | Common side effects of Butriptyline include [[dry mouth]], [[constipation]], [[urinary retention]], and [[sedation]]. Due to its anticholinergic properties, it may also cause [[blurred vision]] and [[tachycardia]]. | ||
== | ==History== | ||
Butriptyline was first introduced in the 1960s. It was marketed under the trade name Evadyne. However, its use has declined over the years as newer antidepressants, such as [[selective serotonin reuptake inhibitor|SSRIs]] and [[serotonin-norepinephrine reuptake inhibitor|SNRIs]], have become more popular due to their improved safety and tolerability. | |||
== | ==Related pages== | ||
* [[Tricyclic antidepressant]] | |||
* [[Serotonin-norepinephrine reuptake inhibitor]] | |||
* [[Depression (mood)]] | |||
[[Category:Tricyclic antidepressants]] | |||
[[Category:Antidepressants]] | [[Category:Antidepressants]] | ||
Latest revision as of 03:44, 13 February 2025
Overview of the antidepressant drug Butriptyline
| Butriptyline | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Butriptyline, also known by its trade name Evadyne, is a tricyclic antidepressant (TCA) that was developed in the 1960s. It is primarily used for the treatment of depression.
Pharmacology[edit]
Butriptyline is a member of the tricyclic antidepressant class, which works by inhibiting the reuptake of neurotransmitters such as serotonin and norepinephrine in the brain. This action increases the levels of these neurotransmitters in the synaptic cleft, thereby enhancing mood and alleviating depressive symptoms.
Mechanism of Action[edit]

Butriptyline acts primarily as a serotonin-norepinephrine reuptake inhibitor (SNRI). It also has affinity for various receptors, including histamine and muscarinic receptors, which contributes to its side effect profile.
Clinical Use[edit]
Butriptyline is indicated for the treatment of major depressive disorder. It is less commonly used today due to the availability of newer antidepressants with more favorable side effect profiles.
Side Effects[edit]
Common side effects of Butriptyline include dry mouth, constipation, urinary retention, and sedation. Due to its anticholinergic properties, it may also cause blurred vision and tachycardia.
History[edit]
Butriptyline was first introduced in the 1960s. It was marketed under the trade name Evadyne. However, its use has declined over the years as newer antidepressants, such as SSRIs and SNRIs, have become more popular due to their improved safety and tolerability.